Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Ballow

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Journal of the American Academy of Child and Adolescent Psychiatry|December 1, 2006
Family relational factors in pediatric depression and asthma: pathways of effectBeatrice L Wood, Bruce D Miller, Jungha Lim, et al.
Journal of Pediatric Psychology|November 28, 2006
Reliability and validity of the Asthma Trigger Inventory applied to a pediatric populationBeatrice L Wood, Po Ann Cheah, JungHa Lim, et al.
Journal of Clinical Immunology|December 10, 2009
Efficacy, pharmacokinetics, safety, and tolerability of Flebogamma 10% DIF, a high-purity human intravenous immunoglobulin, in primary immunodeficiencyMelvin Berger, Paul J Pinciaro, Arthur Althaus, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|October 27, 2004
Developing resources to teach and assess the core competencies: a collaborative approachVirginia A Reed, G Christian Jernstedt, Mark Ballow, et al.
The Journal of Allergy and Clinical Immunology|June 21, 2012
Immune response modifiers in the treatment of asthma: A PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical ImmunologyMark Ballow, Cezmi A Akdis, Thomas B Casale, et al.
The Laryngoscope|February 24, 2011
Further observations on the role of Staphylococcus aureus exotoxins and IgE in the pathogenesis of nasal polyposisJoel M Bernstein, Cheryl Allen, Gary Rich, et al.
Journal of Clinical Immunology|June 10, 2016
Flebogamma(®) 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency DiseasesMark Ballow, Paul J Pinciaro, Timothy Craig, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 26, 2006
Association of depressive symptoms and disease activity in children with asthma: methodological and clinical implicationsJames Waxmonsky, Beatrice L Wood, Trudy Stern, et al.
Journal of Pediatric Psychology|November 25, 2006
Family emotional climate, depression, emotional triggering of asthma, and disease severity in pediatric asthma: examination of pathways of effectBeatrice L Wood, JungHa Lim, Bruce D Miller, et al.
International Immunopharmacology|August 2, 2003
Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trialChaim M Roifman, Harry Schroeder, Melvin Berger, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Journal of the American Academy of Child and Adolescent Psychiatry|December 1, 2006
Family relational factors in pediatric depression and asthma: pathways of effectBeatrice L Wood, Bruce D Miller, Jungha Lim, et al.
Journal of Pediatric Psychology|November 28, 2006
Reliability and validity of the Asthma Trigger Inventory applied to a pediatric populationBeatrice L Wood, Po Ann Cheah, JungHa Lim, et al.
Journal of Clinical Immunology|December 10, 2009
Efficacy, pharmacokinetics, safety, and tolerability of Flebogamma 10% DIF, a high-purity human intravenous immunoglobulin, in primary immunodeficiencyMelvin Berger, Paul J Pinciaro, Arthur Althaus, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|October 27, 2004
Developing resources to teach and assess the core competencies: a collaborative approachVirginia A Reed, G Christian Jernstedt, Mark Ballow, et al.
The Journal of Allergy and Clinical Immunology|June 21, 2012
Immune response modifiers in the treatment of asthma: A PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical ImmunologyMark Ballow, Cezmi A Akdis, Thomas B Casale, et al.
The Laryngoscope|February 24, 2011
Further observations on the role of Staphylococcus aureus exotoxins and IgE in the pathogenesis of nasal polyposisJoel M Bernstein, Cheryl Allen, Gary Rich, et al.
Journal of Clinical Immunology|June 10, 2016
Flebogamma(®) 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency DiseasesMark Ballow, Paul J Pinciaro, Timothy Craig, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 26, 2006
Association of depressive symptoms and disease activity in children with asthma: methodological and clinical implicationsJames Waxmonsky, Beatrice L Wood, Trudy Stern, et al.
Journal of Pediatric Psychology|November 25, 2006
Family emotional climate, depression, emotional triggering of asthma, and disease severity in pediatric asthma: examination of pathways of effectBeatrice L Wood, JungHa Lim, Bruce D Miller, et al.
International Immunopharmacology|August 2, 2003
Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trialChaim M Roifman, Harry Schroeder, Melvin Berger, et al.
Pageof 10